| SETD2 |
Malignant neoplasm of breast |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| SETD2 |
Malignant Neoplasms |
group |
Neoplastic Process |
0.35 |
DisGeNET |
| SETD2 |
Renal Cell Carcinoma |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| SETD2 |
Adenoid Cystic Carcinoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
Phyllodes Tumor |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
leukemia |
disease |
Neoplastic Process |
0.35 |
DisGeNET |
| SETD2 |
Leukemia, Myelocytic, Acute |
disease |
Neoplastic Process |
0.32 |
DisGeNET |
| SETD2 |
Prostatic Neoplasms |
group |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
Sotos' syndrome |
disease |
Disease or Syndrome |
0.30 |
DisGeNET |
| SETD2 |
Conventional (Clear Cell) Renal Cell Carcinoma |
disease |
Neoplastic Process |
0.70 |
DisGeNET |
| SETD2 |
Malignant mesothelioma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
Malignant neoplasm of prostate |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| SETD2 |
Malignant Cystosarcoma Phyllodes |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
Breast Carcinoma |
disease |
Neoplastic Process |
0.40 |
DisGeNET |
| SETD2 |
Microsatellite Instability |
phenotype |
Pathologic Function |
0.30 |
DisGeNET |
| SETD2 |
Mammary Neoplasms, Human |
group |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
Chromophobe Renal Cell Carcinoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
Sarcomatoid Renal Cell Carcinoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
Collecting Duct Carcinoma of the Kidney |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
Papillary Renal Cell Carcinoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
Mammary Neoplasms |
group |
Neoplastic Process |
0.32 |
DisGeNET |
| SETD2 |
Neurodevelopmental Disorders |
group |
Mental or Behavioral Dysfunction |
0.30 |
DisGeNET |
| SETD2 |
Replication Error Phenotype |
phenotype |
Cell or Molecular Dysfunction |
0.30 |
DisGeNET |
| SETD2 |
Precursor Cell Lymphoblastic Leukemia Lymphoma |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
NONPAPILLARY RENAL CARCINOMA 1 LOCUS |
phenotype |
Finding |
0.30 |
DisGeNET |
| SETD2 |
LEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1 |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1 |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO |
disease |
Neoplastic Process |
0.30 |
DisGeNET |
| SETD2 |
LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO |
phenotype |
Finding |
0.30 |
DisGeNET |
| SETD2 |
LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO |
phenotype |
Finding |
0.30 |
DisGeNET |
| SETD2 |
LEUKEMIA, ACUTE MYELOID, SUSCEPTIBILITY TO |
phenotype |
Finding |
0.30 |
DisGeNET |
| SETD2 |
Intellectual Disability |
group |
Mental or Behavioral Dysfunction |
0.41 |
DisGeNET |
| SETD2 |
LUSCAN-LUMISH SYNDROME |
disease |
Disease or Syndrome |
0.60 |
DisGeNET |